About Mabtas 500 Mg Injection
Ending Soon: Secure Mabtas 500 Mg Injection, a top-rated monoclonal antibody therapy, now available with limited stock. Crafted for valiant hospital treatments and distinguished by its unparalleled efficacy, Mabtas features 10 mg/ml Rituximab in a glass vial (500 mg in 50 mL). Specially designed for intravenous infusion and requiring dilution prior to use, this prescription-only medicine from Intas Pharma is intended for adults battling colorectal cancer and B-cell lymphoma. Supplied in a white and green box, Mabtas upholds reliability for hospital supply across India. Store at 2-8C, cool and dry place.
Key Features and Application Details for Mabtas 500 Mg Injection
Mabtas 500 Mg Injection brings unparalleled efficiency to monoclonal antibody therapy with Rituximab, ideal for valiant efforts against colorectal cancer and B-cell lymphoma. Its distinguished formulation is delivered through intravenous infusion after proper dilution. Suitable for hospital supply, Mabtas is intended for adult patients and packaged securely in a white and green box for protection. Always adhere to prescribed dosage guidelines to optimize clinical outcomes and ensure patient safety.
Domestic Market Reach and Packaging of Mabtas 500 Mg Injection
Mabtas 500 Mg Injection, with its strong distribution network, is supplied efficiently across India's main domestic market. Available for hospital supply, each unit is safely packed-one glass vial per box-for reliable transportation. The product is marketed by Intas Pharma, with supply terms and asking price provided upon inquiry. Standard FOB Port services streamline the procurement process, ensuring Mabtas arrives in optimal condition to your medical facility.
FAQ's of Mabtas 500 Mg Injection:
Q: How should Mabtas 500 Mg Injection be administered?
A: Mabtas 500 Mg Injection should be administered as an intravenous infusion, following proper dilution and under supervision of a qualified healthcare professional as prescribed.
Q: What conditions is Mabtas 500 Mg Injection recommended for?
A: Mabtas is primarily recommended for adults diagnosed with colorectal cancer and B-cell lymphoma, as prescribed by a physician.
Q: When is the ideal time to use Mabtas 500 Mg Injection in treatment?
A: The timing for Mabtas administration is determined by your physician based on individual treatment plans and disease stage.
Q: Where should Mabtas 500 Mg Injection be stored after procurement?
A: It should be stored in a cool, dry place at a temperature of 2-8C to maintain efficacy and safety.
Q: What is the process for acquiring Mabtas 500 Mg Injection for hospital use?
A: Hospitals and medical suppliers can contact distributors or Intas Pharma directly, with details on asking price and supply available on request.
Q: What are the benefits of using Mabtas 500 Mg Injection over other treatments?
A: Mabtas offers a distinguished, top-rated monoclonal antibody solution with a proven track record for efficacy in colorectal cancer and lymphoma management.